The Occluded Artery Trial (OAT) Viability Ancillary Study (OAT-NUC): Influence of infarct zone viability on left ventricular remodeling after percutaneous coronary intervention versus optimal medical therapy alone

Autor: Paulo Caramori, Mariusz Kruk, Sandra A. Forman, Eric A. Cohen, Camille A. Pearte, Bartosz Bychowiec, Zygmunt Sadowski, James E. Udelson, José Antonio Marin-Neto, Christopher Adlbrecht, Carey Kimmelstiel, Gervasio A. Lamas, Judith S. Hochman, Witold Rużyłło, Debra Kinan, Anna Teresińska, Joseph A. Kufera, Benita Busz-Papiez, Thomas Höchtl

Publikováno v: Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP

Background The Occluded Artery Trial (OAT) showed no difference in outcomes between percutaneous coronary intervention (PCI) versus optimal medical therapy (MED) in patients with persistent total occlusion of the infarct-related artery 3 to 28 days p

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a020a3bd7e2f8f9d79e5f223631b58f
https://doi.org/10.1016/j.ahj.2010.11.020

Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure. SOLVD Investigators

Autor: Debra Kinan, M W Kronenberg, James E. Udelson, D Stewart, Marvin A. Konstam, T R Edens, Noreen Dolan, S Ahn, J Melin, M F Rousseau

Publikováno v: Circulation. 86:431-438

BACKGROUND In patients with heart failure, activation of the renin-angiotensin system is common and has been postulated to provide a stimulus for further left ventricular (LV) structural and functional derangement. We tested the hypothesis that chron

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67ac0f10a74813d3b43e9f0893ba36d9
https://doi.org/10.1161/01.cir.86.2.431

Peripheral vascular endothelial function correlates with exercise capacity in cardiac transplant recipients

Autor: Jeffrey T. Kuvin, Ayan R. Patel, Debra Kinan, Natesa G. Pandian, David DeNofrio, Kalyani P. Eranki, Richard H. Karas, Kathleen A. Sliney, Marvin A. Konstam, James E. Udelson

Publikováno v: The American journal of cardiology. 91(7)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::958d87e9191960178ea91f126f94cf13
https://pubmed.ncbi.nlm.nih.gov/12667585

Effects of losartan and captopril on left ventricular volumes in elderly patients with heart failure: results of the ELITE ventricular function substudy

Autor: Richard D. Patten, Kenneth La Bresh, Debra Kinan, William M. Rand, John J. Smith, K. Stanley Self, Vera Bittner, Alan H. Gradman, Marvin A. Konstam, Robert Segal, Tarik M. Ramahi, Steven Goldman, Tim Ford, William R. Lewis, Ignatious Thomas, James E. Udelson

Publikováno v: American heart journal. 139(6)

The mechanism by which angiotensin-converting enzyme inhibitors reduce mortality rates and disease progression in patients with heart failure is likely mediated in part through prevention of adverse ventricular remodeling. This study examined the eff

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fca64e3aa4b26ec8fa655af17c1b6627
https://pubmed.ncbi.nlm.nih.gov/10827391

Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dilatation in patients with asymptomatic systolic dysfunction. SOLVD (Studies of Left Ventricular Dysfunction) Investigators

Autor: T R Edens, Debra Kinan, S Ahn, Noreen Dolan, D Stewart, M W Kronenberg, J Melin, Marvin A. Konstam, M F Rousseau, James E. Udelson

Publikováno v: Circulation. 88(5 Pt 1)

BACKGROUND Patients with heart failure and reduced left ventricular (LV) ejection fraction (EF) manifest progressive LV dilatation, which is prevented by angiotensin converting enzyme (ACE) inhibitors. In patients with asymptomatic LV systolic dysfun

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b3429d403ba8e9fa555edada396578e
https://pubmed.ncbi.nlm.nih.gov/8222122